Skip to main content
. 2022 Oct 15;11(6):2205–2217. doi: 10.1007/s40121-022-00703-y

Table 5.

Secondary outcomes (COVID-19-positive patients)

Serial number Symptoms BCG group (n = 246) Placebo group (n = 249) p value
1 Severe COVID-19 infection 0 6 (2.4%) 0.03
2 Hospitalisation 0 6 0.03
3 Oxygen requirement 0 6 0.03
4 ICU admission 0 1 NC
5 Death 0 1 NC

NC not calculated owing to no events in the BCG arm